State Street SPDR S&P Biotech ETF (XBI) Stock Price Today—Real Time Charts and Quotes

Q: What are the 52-week high and low prices for State Street SPDR S&P Biotech ETF (XBI)?

XBI has a 52-week high of $156.66 and a 52-week low of $147.15, with the current price at $149.99.

Q: What is the price-to-earnings (P/E) ratio of State Street SPDR S&P Biotech ETF (XBI)? What does it indicate?

The current P/E ratio (TTM) of XBI is 0, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Asset Management industry for a better context.

Q: What is the market cap of State Street SPDR S&P Biotech ETF (XBI)?

State Street SPDR S&P Biotech ETF (XBI) currently has a market cap of approximately $7.86B.

Q: What is the most recent quarterly earnings per share (EPS) for State Street SPDR S&P Biotech ETF (XBI)?

State Street SPDR S&P Biotech ETF (XBI)'s diluted earnings per share (Diluted EPS) is --. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell State Street SPDR S&P Biotech ETF (XBI) now?

As of now, XBI is trading at $149.99, with a P/E ratio of 0 and a diluted EPS of --. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering State Street SPDR S&P Biotech ETF's financial reports, the outlook of the Asset Management sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of State Street SPDR S&P Biotech ETF (XBI)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Asset Management sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy State Street SPDR S&P Biotech ETF (XBI) stock?

You can buy State Street SPDR S&P Biotech ETF (XBI) through Gate. Sign up for a Gate account and complete identity verification, then go to the State Street SPDR S&P Biotech ETF trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$149.99

-$0.60(-0.39%)

*Data last updated: 2026-07-29 05:20 (UTC+8)

As of 2026-07-29 05:20, State Street SPDR S&P Biotech ETF (XBI) is priced at $149.99, with a total market cap of $7.86B, a P/E ratio of 0.00, and a dividend yield of 0.00%. Today, the stock price fluctuated between $147.15 and $152.15. The current price is 1.93% above the day's low and 1.41% below the day's high, with a trading volume of 7.38M. Over the past 52 weeks, XBI has traded between $147.15 to $156.66, and the current price is -4.25% away from the 52-week high.

Key Stats

Yesterday's Close$152.23

Market Cap$7.86B

Volume7.38M

P/E Ratio0.00

Dividend Yield (TTM)0.00%

Dividend Amount$0.13

Net Income (FY)$0.00

Revenue (FY)$0.00

Revenue Estimate$0.00

Shares Outstanding51.68M

Beta (1Y)1.1

Ex-Dividend Date2026-06-22

Dividend Payment Date2026-06-24

Introduction

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

SectorFinancial Services

IndustryAsset Management

HeadquartersBoston,MA,US

Official Websitehttps://www.ssga.com/us/en/intermediary/etfs/funds/spdr-sp-biotech-etf-xbi

XBI FAQ

What's the stock price of State Street SPDR S&P Biotech ETF (XBI) today?

x

State Street SPDR S&P Biotech ETF (XBI) is currently trading at $149.99, with a 24h change of -0.39%. The 52-week trading range is $147.15–$156.66.

What are the 52-week high and low prices for State Street SPDR S&P Biotech ETF (XBI)?

x

What is the price-to-earnings (P/E) ratio of State Street SPDR S&P Biotech ETF (XBI)? What does it indicate?

x

What is the market cap of State Street SPDR S&P Biotech ETF (XBI)?

x

What is the most recent quarterly earnings per share (EPS) for State Street SPDR S&P Biotech ETF (XBI)?

x

Should you buy or sell State Street SPDR S&P Biotech ETF (XBI) now?

x

What factors can affect the stock price of State Street SPDR S&P Biotech ETF (XBI)?

x

How to buy State Street SPDR S&P Biotech ETF (XBI) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

State Street SPDR S&P Biotech ETF Price